Jonathan Langley Appointment

ATXA Therapeutics & PAH Hope are delighted to welcome Jonathan Langley on board as a non-executive director. Jonathan has vast experience in Pulmonary Arterial Hypertension.


Recent Posts
Archive
Search By Tags